Condition

Developmental and Epileptic Encephalopathy

ClinicalTrials.gov condition label

Clinical trials2

Recruiting0

Common interventions3

Lead sponsors shown1

Clinical trials

2 shown

Open-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic EncephalopathyNCT05626634 · 2022-11-08

COMPLETED

Study to Investigate LP352 in Subjects With Developmental and Epileptic EncephalopathiesNCT05364021 · 2022-03-03

COMPLETED

Common interventions

LP352DRUG1LP352, bexicaserinDRUG1PlaceboDRUG1

Leading sponsors

Longboard Pharmaceuticals2

Trial status mix

COMPLETED2

Phase mix

PHASE22

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.